ArticleMikrochimica acta2026
Engineering glycine-derived carbon dots for selective and portable dual-mode sensing of vitamin B
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Glycine (Gly) was employed as a primary precursor to prepare two types of carbon dots (CDs): glycine-derived nitrogen-doped CDs (Gly-NCDs) and glycine-derived nitrogen/chlorine co-doped CDs (Gly-NClCDs). The latter were obtained by introducing diethylenetriamine and concentrated hydrochloric acid during the synthesis process. The structural and optical properties of the two types of CDs were systematically investigated and compared, revealing that their distinct photoluminescence behaviors likely originate from differences in surface states and elemental doping. These findings provide practical insights into regulating quantum yield, optical characteristics, and particle size without resorting to complex synthetic procedures or expensive reagents. Riboflavin (VB2) is an essential micronutrient involved in various physiological processes, and its rapid and cost-effective determination is of practical importance. Gly-NCDs exhibited good selectivity and a wide linear response range for VB2 detection, enabling ratiometric fluorescence sensing over a concentration range 0.50‒35.70 µM with a detection limit of 1.47 µM. To enhance practical applicability, a smartphone-based sensing platform was further developed for portable and real-time VB2 detection under both visible and UV illumination. This platform achieved detection ranges of 5.00‒45.00 µM, with detection limits of 1.76 µM and 1.36 µM, respectively. The proposed method was successfully validated by determining VB2 in pharmaceutical formulations and human serum samples, demonstrating acceptable accuracy and reproducibility. Overall, this work highlights the potential of glycine-derived CDs as low-cost, scalable, and portable nanoprobes for applications in drug quality control, environmental monitoring, and point-of-care analysis.
Indexed as
Identifiers
41776111What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.